Skip to main content
Premium Trial:

Request an Annual Quote

Orchid BioSciences Pockets $20M in Stock Offering

NEW YORK, Feb. 27 - Orchid BioSciences on Wednesday said it has pocketed approximately $20 million in a special stock offering announced last week.

Orchid said it sold 8 million shares of common stock that were offered through a prospectus supplement  in-line with the company's shelf-registration.

Robertson Stephens acted as the underwriter of the offering, and Orchid has granted the financial firm the option to buy as many as 1.2 million more. If taken, this option would dump $3 million more into Orchid's pot.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.